Potential COVID-19 drugs and their Patents in major jurisdictions-Report

Coronavirus has now become a pandemic. As consistent with a scenario report launched by WHO on April 15, 2020, around 1.91 million humans are tormented by this disorder alongside 0.12 million deaths. The Sudden outbreak of the disorder has struck a lot of countries napping with regards to their healthcare systems and has set the pharmaceutical and biotech corporations around the world in a frenzy to result in a treatment for this hastily spreading the deadly disease.

Some outstanding molecules have arisen and are in different stages of the clinical trial 2. Certain Lead molecules which are potential applicants for the treatment of COVID-19 and are presently in different stages of medical trials in various countries/jurisdictions.

Having detailed research about the threads & Opportunity may lead you to a better position to target.

  • EOU/ Infringement Search
  • Technology Scouting
  • Portfolio Analysis
  • Patent/Technology Landscape
  • Top Players in the market
Report

Potential COVID-19 drugs and their Patents in major jurisdictions

Potential COVID-19 drugs and their Patents in major jurisdictions

Download the Report

Send download link to:

About TTC

We’ve constantly identified the value of new technology carried out by our pretty skilled executive crew with backgrounds as our professionals. Like the IP professionals we empower, our starvation for development is never-ending. We IMPROVISE, ADAPT, and IMPLEMENT in a strategic manner. 

You also can Contact Us to set up a consultation. 

TT Consultants offers a range of efficient, high-quality solutions for your intellectual property management ranging from Patentability SearchInvalidation SearchFTO (Freedom to Operate)Patent Portfolio OptimizationPatent MonitoringInfringement SearchPatent Drafting & Illustrationsand much more. We provide both law firms and corporations in many industries with turnkey solutions. 

Insights

More Related Articles

protein sequence analysis biotechnology

Sequence-Based Freedom-to-Operate for a Clinical-Stage Antibody

The Patent That Looked Non-Essential – Until We Decoded the Math

EV Patent Infringement Analysis for 3,500+ Patents with TT Consultants

How a Global EV Giant Converted 3,500+ Patents into Validated Infringement Intelligence in 6 Weeks